Titre:
  • Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer.
Auteur:Lan, Qiang; Peyvandi, Sanam; Duffey, Nathalie; Huang, Yu-Ting; Barras, David; Held, Werner; Richard, François; Delorenzi, Mauro; Sotiriou, Christos; Desmedt, Christine; Lorusso, Girieca; Rüegg, Curzio
Informations sur la publication:Oncogene
Statut de publication:Publié, 2018-12-01
Sujet CREF:Cancérologie
Sciences bio-médicales et agricoles
Médecine pathologie humaine
MeSH keywords:Animals
Antineoplastic Combined Chemotherapy Protocols -- pharmacology
Biomarkers, Tumor -- metabolism
Breast Neoplasms -- drug therapy -- metabolism
Cell Line, Tumor
Chemotherapy, Adjuvant -- methods
Doxorubicin -- pharmacology
Epirubicin -- pharmacology
Female
Humans
Interferon Regulatory Factor-7 -- metabolism
Interferon Type I -- metabolism
Interferon-beta -- metabolism
Methotrexate -- pharmacology
Mice
Mice, Inbred BALB C
Mice, Inbred NOD
Mice, Nude
Mice, SCID
Neoadjuvant Therapy -- methods
Neoplasm Recurrence, Local -- metabolism
Receptor, ErbB-2 -- metabolism
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0950-9232
info:doi/10.1038/s41388-018-0624-2
info:pii/10.1038/s41388-018-0624-2
info:scp/85058436373
info:pmid/30546090
PMC6477891